Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma

Clinical Lung Cancer

Volumn 14, Issue 5, 2013, Pages 521-526

  Tomonaga, Nanae ^a   Nakamura, Yoichi ^a   Yamaguchi, Hiroyuki ^a   Ikeda, Takaya ^a   Mizoguchi, Kosuke ^a   Motoshima, Kohei ^a   Doi, Seiji ^a   Nakatomi, Katsumi ^a   Iida, Tetsuya ^a   Hayashi, Tomayoshi ^b   Nagayasu, Takeshi ^c   Tsukamoto, Kazuhiro ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

EGFR mutations; Heterogeneity; Mixed type adenocarcinoma; Non small cell lung cancer; Smoking

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; DNA EXTRACTION; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOGENESIS; LUNG NODULE; MALE; RADIATION INJURY; RADIATION PNEUMONIA; RECURRENT CANCER; RNA ANALYSIS; SMOKING; WILD TYPE;

EGFR MUTATIONS; HETEROGENEITY; MIXED TYPE ADENOCARCINOMA; NON-SMALL-CELL LUNG CANCER; SMOKING;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, PAPILLARY; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER CAPTURE MICRODISSECTION; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMOKING; SURVIVAL RATE;

EID: 84883769948     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.04.005     Document Type: Article

References (31)

1. J.H. Schiller, D. Harrington, and C.P. Belani Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 2002 92 98
2. Y. Ohe, Y. Ohashi, and K. Kubota Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan Ann Oncol 18 2007 317 323
3. I. Uberall, Z. Kolar, and R. Trojanec The status and role of ErbB receptors in human cancer Exp Mol Pathol 84 2008 79 89
4. R.N. Jorissen, F. Walker, and N. Pouliot Epidermal growth factor receptor: mechanisms of activation and signalling Exp Cell Res 284 2003 31 53
5. T.J. Lynch, D.W. Bell, and R. Sordella Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
6. J.G. Paez, P.A. Janne, and J.C. Lee EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
7. W. Pao, V. Miller, and M. Zakowski EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci U S A 101 2004 13306 13311
8. T. Mitsudomi, and Y. Yatabe Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer Cancer Sci 98 2007 1817 1824
9. M. Maemondo, A. Inoue, and K. Kobayashi Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 2010 2380 2388
10. T. Mitsudomi, S. Morita, and Y. Yatabe Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Lancet Oncol 11 2010 121 128
11. W.D. Travis, E. Brambilla, and M. Noguchi International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidiscliplinary classification of lung adenocarcinoma J Thorac Oncol 6 2011 244 285
12. H. Nakano, H. Soda, and M. Takasu Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule Lung Cancer 60 2008 136 140
13. J.C. Soria, E.S. Kim, and J. Fayette Chemoprevention of lung cancer Lancet Oncol 4 2003 659 669
14. W.D. Travis, E. Brambilla, and H.K. Müller-Hermelink Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart 2004 IARC Lyon
15. H. Asano, S. Toyooka, and M. Tokumo Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay Clin Cancer Res 12 2006 43 48
16. T. Mitsudomi Advances in target therapy for lung cancer Jpn J Clin Oncol 40 2009 101 106
17. K. Sugio, H. Uramoto, and K. Ono Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking Br J Cancer 94 2006 896 903
18. W. Pao, V.A. Miller, and M.G. Kris 'Targeting' the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC) Semin Cancer Biol 14 2004 33 40
19. T. Takano, Y. Ohe, and M. Kusumoto Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib Lung Cancer 45 2004 93 104
20. M. Noguchi, A. Morikawa, and M. Kawasaki Small adenocarcinoma of the lung. Histologic characteristics and prognosis Cancer 75 1995 2844 2852
21. S. Takashima, Y. Maruyama, and M. Hasegawa CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern AJR Am J Roentgenol 180 2003 817 826
22. X. Tang, M. Varella-Garcia, and A.C. Xavier Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas Cancer Prev Res (Phila) 1 2008 192 200
23. J. Soh, S. Toyooka, and S. Ichihara Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung J Thorac Oncol 3 2008 340 347
24. Y. Yatabe, T. Takahashi, and T. Mitsudomi Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer Cancer Res 68 2008 2106 2111
25. K. Ohashi, K. Rai, and Y. Fujiwara Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP-C promoter Cancer Sci 99 2008 1747 1753
26. K. Taniguchi, J. Okami, and K. Kodama Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib Cancer Sci 99 2008 929 935
27. Y. Yatabe, K. Matsuo, and T. Mitsudomi Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma J Clin Oncol 29 2011 2972 2977
28. J.N. Jakobsen, and J.B. Sørensen Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer Cancer Chemother Pharmacol 69 2012 289 299
29. T. Ikeda, Y. Nakamura, and H. Yamaguchi Direct comparison of 3 PCR methods in detecting EGFR mutations in patients with advanced non-small-cell lung cancer Clin Lung Cancer 13 2012 369 374
30. H. Bai, Z. Wang, and K. Chen Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer J Clin Oncol 30 2012 3077 3083
31. Y. Honda, N. Takigawa, and S. Fushimi Disappearance of an activated EGFR mutation after treatment with EGFR tyrosine kinase inhibitors Lung Cancer 78 2012 121 124